Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis. Gomes D, Wang S, Goodspeed L, Turk KE, et al. J Lipid Res 2022;63:100174.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gomes D, Wang S, Goodspeed L, Turk KE, et al. Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis. J Lipid Res 2022;63:100174.
PMID: 35101425